Midazolam Nasal spray bulk supplier for pharma manufacturers

Midazolam Nasal Spray 2.5 mg, 5 mg, 7.5 mg, 10 mg Suppliers & Bulk Manufacturers

Available Forms: Nasal/Buccal

Available Strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg

Reference Brands: Nayzilam (nasal spray)(US)

Midazolam is a benzodiazepine used for sedation, anesthesia, and seizure management. Available in injectable, nasal, and oral forms, it's marketed as Versed in the US and Buccolam in the EU. A critical ICU and emergency drug, Midazolam is a key product for pharma B2B distributors and hospital suppliers.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Midazolam is a fast-acting benzodiazepine used for sedation, anesthesia induction, and seizure control. Available in various forms like injections (1 mg/mL, 5 mg/mL), oral syrup, nasal spray, and buccal solutions, it is widely used in ICU and emergency settings. In the US, it is marketed under brands like Versed and Nayzilam, while in the EU, Buccolam and Epistatus are common. Midazolam is a high-demand product in hospital and ambulatory care, making it a vital listing for pharmaceutical B2B platforms dealing in anesthesia, emergency care, and neurology segments.

Midazolam Nasal Spray — third party manufacturing & bulk supply

Midazolam Nasal Spray 2.5 mg, 5 mg, 7.5 mg, 10 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Midazolam Nasal Spray is supplied as Nasal/Buccal — a dosage form priced by order value, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Midazolam Nasal Spray listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Midazolam Nasal Spray →

Back to Listing

Frequently Asked Questions

Midazolam nasal spray is used for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity, also known as seizure clusters or acute repetitive seizures, in patients with epilepsy. It is designed for rapid administration through the nose to quickly control seizures outside of a hospital setting.

Midazolam nasal spray is made from the active pharmaceutical ingredient midazolam hydrochloride. It belongs to the benzodiazepine class of medicines and works by enhancing the effect of gamma-aminobutyric acid (GABA), a neurotransmitter that helps calm excessive electrical activity in the brain.

The main trade name in the United States is Nayzilam. In Europe and the United Kingdom, midazolam is commonly available as Buccolam in an oromucosal (buccal) formulation.

Nayzilam is marketed by UCB Inc. Buccolam is marketed by Neuraxpharm in several European countries.

The generic name is midazolam hydrochloride.

The brand name in the USA is Nayzilam. In Europe and the UK, it is available as Buccolam (buccal formulation).

Midazolam nasal spray products are manufactured in GMP-certified pharmaceutical facilities in the United States and Europe, depending on the brand owner and marketing authorization holder. Specific manufacturing locations may vary by region and batch.